Legal & General Group PLC United Therapeutics Corp Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Legal & General Group PLC holds 242,825 shares of UTHR stock, worth $87.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
242,825
Previous 242,825 -0.0%
Holding current value
$87.4 Million
Previous $87 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$311.04 - $363.55 $5.45 Million - $6.37 Million
-17,524 Reduced 6.73%
242,825 $87 Million
Q2 2024

Aug 14, 2024
SELL
$228.26 - $319.04 $1.53 Million - $2.14 Million
-6,716 Reduced 2.51%
260,349 $82.9 Million
Q1 2024

May 14, 2024
SELL
$210.76 - $249.51 $2.69 Million - $3.19 Million
-12,780 Reduced 4.57%
267,065 $61.4 Million
Q4 2023

Feb 15, 2024
BUY
$214.88 - $256.94 $12.9 Million - $15.5 Million
60,242 Added 27.43%
279,845 $61.5 Million
Q3 2023

Nov 14, 2023
SELL
$211.82 - $248.24 $410,083 - $480,592
-1,936 Reduced 0.87%
219,603 $49.6 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $977,525 - $1.11 Million
4,764 Added 2.2%
221,539 $48.9 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $20.4 Million - $26.5 Million
95,909 Added 79.35%
216,775 $48.5 Million
Q4 2022

Feb 14, 2023
BUY
$205.95 - $280.43 $1.2 Million - $1.63 Million
5,813 Added 5.05%
120,866 $33.6 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $718,665 - $863,140
-3,535 Reduced 2.98%
115,053 $24.1 Million
Q2 2022

Aug 22, 2022
SELL
$174.81 - $241.14 $310,112 - $427,782
-1,774 Reduced 1.47%
118,588 $27.9 Million
Q1 2022

May 16, 2022
BUY
$166.16 - $213.96 $437,166 - $562,928
2,631 Added 2.23%
120,362 $21.6 Million
Q4 2021

Feb 14, 2022
BUY
$184.32 - $216.08 $579,502 - $679,355
3,144 Added 2.74%
117,731 $25.4 Million
Q3 2021

Nov 15, 2021
BUY
$179.86 - $214.88 $90,289 - $107,869
502 Added 0.44%
114,587 $21.2 Million
Q2 2021

Aug 12, 2021
SELL
$170.47 - $211.93 $2.64 Million - $3.28 Million
-15,470 Reduced 11.94%
114,085 $20.5 Million
Q1 2021

May 17, 2021
SELL
$153.94 - $174.85 $202,431 - $229,927
-1,315 Reduced 1.0%
129,555 $21.7 Million
Q4 2020

Feb 12, 2021
SELL
$101.87 - $151.79 $686,196 - $1.02 Million
-6,736 Reduced 4.9%
130,870 $19.9 Million
Q3 2020

Nov 13, 2020
BUY
$99.9 - $121.13 $282,816 - $342,919
2,831 Added 2.1%
137,606 $13.9 Million
Q2 2020

Aug 14, 2020
BUY
$92.74 - $125.82 $909,315 - $1.23 Million
9,805 Added 7.85%
134,775 $16.3 Million
Q1 2020

May 14, 2020
SELL
$79.39 - $115.35 $143,695 - $208,783
-1,810 Reduced 1.43%
124,970 $11.8 Million
Q4 2019

Feb 13, 2020
BUY
$78.31 - $95.34 $392,959 - $478,416
5,018 Added 4.12%
126,780 $11.2 Million
Q3 2019

Nov 13, 2019
BUY
$74.85 - $85.99 $607,482 - $697,894
8,116 Added 7.14%
121,762 $9.71 Million
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $3.83 Million - $6.09 Million
-50,413 Reduced 30.73%
113,646 $8.87 Million
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $5.51 Million - $6.52 Million
51,428 Added 45.66%
164,059 $19.3 Million
Q4 2018

Feb 15, 2019
BUY
$101.4 - $128.73 $1.18 Million - $1.5 Million
11,664 Added 11.55%
112,631 $12.3 Million
Q3 2018

Nov 20, 2018
BUY
$113.81 - $129.46 $273,030 - $310,574
2,399 Added 2.43%
100,967 $12.9 Million
Q2 2018

Aug 10, 2018
SELL
$101.14 - $118.31 $33,376 - $39,042
-330 Reduced 0.33%
98,568 $11.2 Million
Q1 2018

May 17, 2018
BUY
$107.21 - $151.94 $767,194 - $1.09 Million
7,156 Added 7.8%
98,898 $11.1 Million
Q4 2017

Feb 13, 2018
BUY
$118.58 - $151.28 $10.9 Million - $13.9 Million
91,742
91,742 $13.6 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email